June 26, 2026 · Form 4 insider transaction
Warren Eric bought 104,124 shares of Mineralys Therapeutics, Inc. at $13.24 per share, a transaction worth $1.38M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026.